These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3169090)

  • 1. The isolation and characterization of cisplatin-resistant rat ovarian cancer cells.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Nagao K; Takamizawa H
    Eur J Cancer Clin Oncol; 1988 May; 24(5):851-9. PubMed ID: 3169090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Akaboshi M; Takamizawa H
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):429-37. PubMed ID: 2702997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro studies on the antitumor effect of cis-diamminedichloroplatinum II (cisplatin) against ovarian adenocarcinoma cell line of the rat].
    Sekiya S; Iwasawa H; Takamizawa H; Sugita M; Tenjin Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1487-90. PubMed ID: 6890087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies on the antitumor effect of cis-dichlorodiammineplatinum(II) against transplantable ovarian adenocarcinoma cells of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Gynecol Oncol; 1983 Aug; 16(1):85-94. PubMed ID: 6684077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC; Hamilton TC; Masuda H; Grotzinger KR; Whang-Peng J; Louie KG; Knutsen T; McKoy WM; Young RC; Ozols RF
    Cancer Res; 1987 Jan; 47(2):414-8. PubMed ID: 3539322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance.
    Dong QG; Gong LL; Wang HJ; Wang EZ
    Anticancer Drugs; 1993 Dec; 4(6):617-27. PubMed ID: 8298162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.
    Schilder RJ; Hall L; Monks A; Handel LM; Fornace AJ; Ozols RF; Fojo AT; Hamilton TC
    Int J Cancer; 1990 Mar; 45(3):416-22. PubMed ID: 2307530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
    O'Neill CF; Hunakova L; Kelland LR
    Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effect of cis-diamminedichloroplatinum (II) against transplantable ovarian adenocarcinoma cells of the rat].
    Iwasawa H; Sekiya S; Takamizawa H
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1785-90. PubMed ID: 6892193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro.
    Oldenburg J; Begg AC; van Vugt MJ; Ruevekamp M; Schornagel JH; Pinedo HM; Los G
    Cancer Res; 1994 Jan; 54(2):487-93. PubMed ID: 8275486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titanocendichloride activity in cisplatin and doxorubicin-resistant human ovarian carcinoma cell lines.
    Harstrick A; Schmoll HJ; Sass G; Poliwoda H; Rustum Y
    Eur J Cancer; 1993; 29A(7):1000-2. PubMed ID: 8499130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
    Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
    Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells.
    Parekh H; Simpkins H
    Cancer Chemother Pharmacol; 1996; 37(5):457-62. PubMed ID: 8599869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
    Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
    Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y; Chen H; Yang Q
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):680-3. PubMed ID: 9275551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N; Adachi S; Misawa Y; Yuzawa H; Honda T; Kanazawa K; Takeuchi S Tanaka K; Tanaka K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):7-14. PubMed ID: 2647872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells.
    Horváth V; Blanárová O; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Fedorocko P; Kozubík A
    Gynecol Oncol; 2006 Jul; 102(1):32-40. PubMed ID: 16364413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoresistance in rat ovarian tumours.
    Zeller WJ; Frühauf S; Chen G; Keppler BK; Frei E; Kaufmann M
    Eur J Cancer; 1991; 27(1):62-7. PubMed ID: 1826445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
    Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.